Efficacy of Nirsevimab Over 6 Months: A 180-Day Endpoint Analysis from the HARMONIE Study, a Randomized Phase IIIb trial
Alasdair P.S. Munro, PhD1, 2., Simon B. Drysdale, PhD., FRCPCH3, 4., Katrina Cathie, MD., FRCPCH1, 2., Florence Flamein, MD., PhD5, 6., Markus Knuf, PhD7, 8., Andrea M. Collins, MD., PhD9,10., Helen C. Hill, PhD9., Friedrich Kaiser, MD11., Robert Cohen, MD12., Didier Pinquier, MD13., Natalya C. Vassilouthis, MD14., Mariana Carreno, MD15., Catherine Moreau, MSc16., Pierre Bourron, PharmD17., Lydie Marcelon, PhD18., Karine Mari, PhD19., Michelle Roberts, MD20., Pierre Tissières, MD., DSc21,22., Simon Royal, MPH., MRCGP23., and Saul N. Faust, PhD., FRCPCH1, 2., for the HARMONIE Study Group. doi:10.2139/ssrn.4995419..
